PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsAttention deficit disorder with hyperactivity
MeSH D001289 - attention deficit disorder with hyperactivity
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D019958:Attention deficit and disruptive behavior disorders
$
Success rate
D001289: 
Attention deficit disorder with hyperactivity
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Abbott BiotherapeuticsImipramine Janimine  1982-01-01   
Able LaboratoriesDextroamphetamine Dextroamphetamine  2004-08-25   
Methamphetamine Methamphetamine  2004-02-25   
Methylphenidate Methylphenidate  2001-03-29   
Accord HealthcareBupropion Bupropion  2018-10-31   
Amphetamine, Dextroamphetamine, Dextroamphetamine saccharate, Amphetamine aspartate Dextroamp Saccharate, Amp Aspartate, Dextroamp Amp  2021-11-22   
Methylphenidate Methylphenidate  2020-10-28   
Adare PharmaceuticalsDexmethylphenidate Dexmethylphenidate  2018-10-09   
Ajanta PharmaClonidine Clonidine  2017-11-20   
Guanfacine Guanfacine  2023-04-27   
Alembic PharmaceuticalsBupropion Bupropion  2018-06-08   
Clonidine Clonidine  2011-12-06   
Modafinil Modafinil  2012-10-18   
Guanfacine Guanfacine  2023-08-07   
Alkem LaboratoriesAmphetamine Amphetamine  2020-10-27   
Dexmethylphenidate Dexmethylphenidate  2019-07-19   
Methylphenidate Methylphenidate  2020-03-30   
Lisdexamfetamine dimesylate Lisdexamfetamine Dimesylate  2023-08-25   
Amphetamine, Dextroamphetamine, Dextroamphetamine saccharate, Amphetamine aspartate Dextroamp Saccharate, Amp Aspartate, Dextroamp Amp  2023-10-06   
AllerganBupropion Bupropion  2008-08-15   
Clonidine Clonidine  1987-03-23   
Amphetamine, Dextroamphetamine, Dextroamphetamine saccharate, Amphetamine aspartate Dextroamp Saccharate, Amp Aspartate, Dextroamp Amp  2003-05-06   
Dextroamphetamine Dextroamphetamine  2012-11-30   
Guanfacine Guanfacine  1995-10-17   
Imipramine Imipramine  1982-01-01   
Methylphenidate Methylphenidate  1997-08-29   
Modafinil Modafinil  2012-11-01   
Amphetamine Amphetamine  2023-06-22   
Lisdexamfetamine dimesylate Lisdexamfetamine Dimesylate  2023-08-25   
AlraImipramine Pramine  1982-01-01   
1
2
3
4
5
6
...
15
>
Clinical Trials
Historical Success Rate
Phase 1
90%
18/20
Phase 2
50%
24/48
Phase 3
76%
38/50
Approved: 22Overall Success rate: 34%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
1
2
3
4
5
6
...
10
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use